# Dry Eye Treatments

This is a subcategory of Opthalmic Agents.

## Formulary

### Preferred

| Preferred             | Generic Name | Quantity | Time (Days) |
| :-------------------- | :----------- | :------: | :---------: |
| Restasis Trays BvG ST |              |          |             |

### Non-Preferred

| Non-Preferred       | Generic Name | Quantity | Time (Days) |
| :------------------ | :----------- | :------: | :---------: |
| Cequa               |              |          |             |
| Eysuvis             |              |          |             |
| Restasis Multi-Dose |              |          |             |
| Tyrvaya             |              |          |             |
| Xiidra              |              |          |             |

## Length of Authorizations

14 Days for Eysuvis; 365 Days for all other agents

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to all medications not requiring prior approval
-   Contraindication to or drug-to-drug interaction with medications not requiring prior approval.
-   History of unacceptable/toxic side effects to medications not requiring prior approval

All drugs in this class require step therapy: Patient must have a claim for an artificial tear or OTC dry eye drop in the previous 120 days.

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=84)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=28)
